Johnson & Johnson Earmarks Nearly $4 Billion for Talc Powder Lawsuits
As the number of talc powder lawsuits against Johnson & Johnson continues to rise, the multinational corporation has reserved $3.9 billion for litigation expenses and settlements, reports Business Insider. The planned reserve represents a marked increase from the $400 million that Johnson & Johnson (J&J) had earmarked for such expenses in 2019.
Plaintiffs Must Select New Trial for Talc Verdict or Reduced Damage Award
Johnson & Johnson is the defendant in more than 20,000 lawsuits that allege the company’s talcum-based Johnson’s Baby Powder and Shower-to-Shower caused plaintiffs to develop mesothelioma and ovarian cancer. In one such case, Olson v. Brenntag N. Am., Inc., plaintiffs Donna Olson and Robert Olson thought they had won big in their suit.
Johnson & Johnson to Pay Over $100 Million for Talcum Powder Cancer Lawsuits
After four years of litigation between plaintiffs and Johnson & Johnson, the multinational corporation agreed to the first set of major settlements. The agreement to pay $100 million will resolve more than 1,000 lawsuits in which plaintiffs allege that the talc in Johnson & Johnson’s signature baby powder causes cancer, according to a Bloomberg report. This settlement marks the first to come from almost 20,000 lawsuits.
Johnson & Johnson Pulls Talc Baby Powder form U.S. Market
Since the early 1900’s Johnson & Johnson has proudly advertised its Johnson’s Baby Powder as “Best for the Baby—Best for You.” Although the massive, multinational company continues to stand by this message, it has finally conceded to others who disagree by discontinuing sales of its talc-based baby powder in North America.
Coronavirus Disrupts Dockets in Talc Lawsuits
The coronavirus outbreak has touched virtually every aspect of our lives, including our court system. On March 18, a New Jersey state court declared it was delaying proceedings in a case against American International Industries, the parent company for talc-product manufacturer Clubman.
In the lawsuit, two hairdressers, Margaret Lashley and Dwayne Johnson, seek justice for their exposure to asbestos in Clubman brand’s cosmetic talc products they used in a barbershop. The plaintiffs claim that this exposure caused their fatal cancer.
Johnson & Johnson's Winning Streak Ends With $750 Million Verdict for Plaintiffs
A jury in Johnson & Johnson's home state of New Jersey ordered the health care and cosmetic products giant to pay punitive damages of $750 million in a talc mesothelioma case last week. The verdict comes on top of $37 million in compensatory damages awarded to four plaintiffs who claimed their disease was caused by asbestos-contaminated talc.
More Evidence Linking Talcum Powder to Mesothelioma
A new study appearing in the current edition of the Journal of Occupational and Environmental Medicine may provide plaintiffs in talc litigation the most powerful evidence yet discovered linking asbestos-contaminated talcum powder to mesothelioma.
Johnson and Johnson Faces Criminal Investigation Over “No Asbestos” Claims
How much did Johnson & Johnson really know about asbestos contamination of the talc it used in its Baby Powder? A federal grand jury has been impaneled by the US Department of Justice (DoJ) to find an answer to just that question.
Johnson & Johnson Hit With $4.7 Billion Verdict
A group of 22 women suffering from ovarian cancer caused by asbestos-containing talcum powder were vindicated this week when a St. Louis jury ordered health care products manufacturer Johnson & Johnson to pay nearly $4.7 billion in damages.
Jury Finds Johnson & Johnson, Imerys Liable in Lawsuit Claiming Talcum Powder Caused Mesothelioma Cancer
In a stunning verdict handed down in a federal court in New Jersey, a jury has ordered pharmaceutical giant Johnson & Johnson and its talc supplier, Imerys, to pay $37 million to a 46-year-old man who alleged that his mesothelioma was caused by his regular use of the defendant's talc-containing products over the course of his lifetime. The trial, which ended yesterday, is the most recent bellwether case over allegations that Johnson & Johnson's flagship products, Baby Powder and Shower to Shower, are carcinogenic.